Clarix Imaging Revenue and Competitors

Clarix Imaging brings unprecedented clarity to intraoperative breast cancer lumpectomy margin visualization with our true 3D (CT) VSI-360™ Volumetric Specimen Imaging System. This advanced imaging technology takes breast surgeons and radiologists on a Journey Through the Specimen™ with views of any tissue slice from multiple angles – with no obscuring of the margins. Clarix Imaging is the only company to commercially offer a CT breast specimen imaging system.\n \nA venture-backed private company founded by world-renowned medical imaging scientists from the University of Chicago, Clarix Imaging’s mission is to empower clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine based on breakthrough innovations in imaging science and AI. Our first product is the FDA cleared true 3D VSI-360™, which offers radiologists and surgeons unprecedented clarity for intraoperative specimen margin visualization in breast cancer surgeries such as lumpectomy – right inside the operating room. VSI-360™ generates a true 3D image of the specimen in real-time, and its advanced software tools allow users to visualize the tumor in thin image slices without overlapping tissues obscuring the margins.\n\nPartner with us on our journey to advance outcomes in surgical oncology through innovations in imaging.